PcW Releases Report Outlining Trends in Pharmaceutical Supply Chains
Healthcare reform may shift pharmaceutical companies' focus from product features to patient outcomes, according to a report from PricewaterhouseCoopers.
Among the report's six predicted trends, PwC suggests the government's emphasis on health outcomes as a basis for payments will require pharmaceutical companies to combine product offerings with data and supplemental services that add value through improved outcomes and efficiencies.
The five other trends listed in the report include new product types, incremental product launches that can alter sales curves, new modes of healthcare delivery, growing importance of emerging markets and greater public scrutiny.
Read the PwC news release about Supplying the Future: Which path will you take?
Read other coverage about pharmaceutical companies:
- Actavis to Pay $170M for Reporting False Prices to Medicaid
- St. Jude Medical to Pay $16M to Settle Kickback Allegations
- Pharmaceutical Company Will Pay $280M to Settle False Claims Allegations
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
Latest Articles
- ASC Industry Leader to Know: Dr. Gregory Lauro of Laurel Surgical Center
- Ambulatory Alliances Releases Free Webinar on Valuing Ambulatory Surgery Centers
- Louisville Endoscopy Center Earns Three-Year AAAHC Accreditation
- Pain Physician Joins Sarasota Pain Management
- Fentanyl Spray Deemed Safe for Cancer Pain Patients
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,504.48 Trade time:4:02PM EDT Value change:▲135.10 (1.09%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,847.21 Trade time:5:16PM EDT Value change:0.00 (0.00%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,315.99 Trade time:4:32PM EDT Value change:0.00 (0.00%)
Channels
